Robberechts Anneleen, Brumer Maja, Garcia-Cardenas Victoria, Dupotey Niurka M, Steurbaut Stephane, De Meyer Guido R Y, De Loof Hans
Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium.
Meduplace, Royal Pharmacists Association of Antwerp (KAVA), 2018 Antwerp, Belgium.
Pharmacy (Basel). 2024 Feb 19;12(1):39. doi: 10.3390/pharmacy12010039.
Medication review is a multifaceted service aimed at optimizing the use of medicines and enhancing the health outcomes of patients. Due to its complexity, it is crucial to clearly describe the service, its variants, and its components to avoid confusion and ensure a better understanding of medication review among healthcare providers.
This study aims to bring clarity to the origins, definitions, abbreviations, and types of medication reviews, together with the primary criteria that delineate key features of this service.
A narrative review approach was employed to clarify the diverse terminology associated with "medication review" services. Relevant references were initially identified through searches on PubMed and Google Scholar, complementing the existing literature known to the authors.
The study uncovers a complicated and sometimes convoluted history of "medication review" in different regions around the world. The initial optimization of medicine use had an economic purpose before evolving subsequently into a more patient-oriented approach. A selection of abbreviations, definitions, and types were outlined to enhance the understanding of the service.
The study underscores the urgent need for comprehensive information and standardization regarding the content and quality of the services, collectively referred to as "medication review".
药物审查是一项多方面的服务,旨在优化药物使用并改善患者的健康结局。由于其复杂性,清晰描述该服务、其变体及其组成部分至关重要,以避免混淆并确保医疗保健提供者更好地理解药物审查。
本研究旨在阐明药物审查的起源、定义、缩写和类型,以及界定该服务关键特征的主要标准。
采用叙述性综述方法来澄清与“药物审查”服务相关的各种术语。最初通过在PubMed和谷歌学术上搜索来识别相关参考文献,并补充作者已知的现有文献。
该研究揭示了世界各地不同地区“药物审查”复杂且有时错综复杂的历史。药物使用的最初优化具有经济目的,随后逐渐演变成一种更以患者为导向的方法。概述了一系列缩写、定义和类型,以增进对该服务的理解。
该研究强调迫切需要有关统称为“药物审查”的服务内容和质量的全面信息及标准化。